Literature DB >> 31466574

Charcot Neuroarthropathy Advances: Understanding Pathogenesis and Medical and Surgical Management.

Georgeanne Botek1, Samantha Figas2, Sai Narra2.   

Abstract

Understanding new theories of the epidemiology of Charcot neuroarthropathy is practice changing. Treatment of Charcot neuroarthropathy is evolving from a passive approach to one that sees the urgency of proactive, early recognition, thereby avoiding the cascading events that lead to the complex, limb-threatening deformities. Preventive medicine is the most efficient at avoiding severe deformity, with prolonged offloading and immobilization as the current mainstay of treatment. However, with recent advancements in medical and surgical modalities, this may become the treatment of the past as clinicians begin to favor medical management and early surgical intervention.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Charcot advances; Charcot arthropathy; Charcot epidemiology; Charcot joint; Charcot neuroarthropathy; Charcot pathogenesis; Charcot surgical treatment; Neuropathic osteoarthropathy

Year:  2019        PMID: 31466574     DOI: 10.1016/j.cpm.2019.07.002

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  3 in total

1.  Comments on the Article "Results of Simple Conservative Treatment of Midfoot Charcot Arthropathy": In Reply.

Authors:  You Keun Kim; Ho Seong Lee; Sang Gyo Seo; Seung-Hwan Park; Dimas Boedijono
Journal:  Clin Orthop Surg       Date:  2020-05-14

2.  Comments on the Article "Results of Simple Conservative Treatment of Midfoot Charcot Arthropathy": To the Editor.

Authors:  Nicolas Gallardo-Molina
Journal:  Clin Orthop Surg       Date:  2020-05-14

3.  Long-term follow-up of conservative treatment of Charcot feet.

Authors:  Viviane Gratwohl; Thorsten Jentzsch; Madlaina Schöni; Dominik Kaiser; Martin C Berli; Thomas Böni; Felix W A Waibel
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-07       Impact factor: 2.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.